Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-23-000080
Filing Date
2023-02-14
Accepted
2023-02-14 15:51:41
Documents
37
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 abti10q.htm   iXBRL 10-Q 360119
2 GRAPHIC image_001.jpg GRAPHIC 2736
3 ex31_1.htm EX-31.1 9012
4 ex31_2.htm EX-31.2 9022
5 ex32_1.htm EX-32.1 5716
  Complete submission text file 0001663577-23-000080.txt   1946816

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abti-20221231.xsd EX-101.SCH 16484
7 XBRL CALCULATION FILE abti-20221231_cal.xml EX-101.CAL 32492
8 XBRL DEFINITION FILE abti-20221231_def.xml EX-101.DEF 43447
9 XBRL LABEL FILE abti-20221231_lab.xml EX-101.LAB 145916
10 XBRL PRESENTATION FILE abti-20221231_pre.xml EX-101.PRE 119662
31 EXTRACTED XBRL INSTANCE DOCUMENT abti10q_htm.xml XML 161832
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 23628253
SIC: 2833 Medicinal Chemicals & Botanical Products